Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors
- 1 May 2017
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 25 (10) , 2761-2771
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology
- Government of India
This publication has 22 references indexed in Scilit:
- Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosisTuberculosis, 2015
- Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort studyDrug, Healthcare and Patient Safety, 2014
- Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive Mycobacterium tuberculosismBio, 2013
- Reduced Drug Uptake in Phenotypically Resistant Nutrient-Starved Nonreplicating Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2013
- Mycobacterium tuberculosis: success through dormancyFEMS Microbiology Reviews, 2012
- A model 450 million years in the making: zebrafish and vertebrate immunityDisease Models & Mechanisms, 2012
- Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug‐tolerant bacteriaMolecular Microbiology, 2008
- Location of Persisting Mycobacteria in a Guinea Pig Model of Tuberculosis Revealed by R207910Antimicrobial Agents and Chemotherapy, 2007
- Cell‐Wall Alterations as an Attribute ofMycobacterium tuberculosisin Latent InfectionThe Journal of Infectious Diseases, 2003
- Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profilingMolecular Microbiology, 2002